- Home
- SFBC vs ZNTL Comparison
SFBC vs ZNTL Comparison
Compare SFBC & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFBC
- ZNTL
- Stock Information
- Founded
- SFBC 1953
- ZNTL 2014
- Country
- SFBC United States
- ZNTL United States
- Employees
- SFBC N/A
- ZNTL N/A
- Industry
- SFBC Savings Institutions
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- SFBC Finance
- ZNTL Health Care
- Exchange
- SFBC Nasdaq
- ZNTL Nasdaq
- Market Cap
- SFBC 112.5M
- ZNTL 105.8M
- IPO Year
- SFBC N/A
- ZNTL 2020
- Fundamental
- Price
- SFBC $45.75
- ZNTL $1.34
- Analyst Decision
- SFBC
- ZNTL Buy
- Analyst Count
- SFBC 0
- ZNTL 7
- Target Price
- SFBC N/A
- ZNTL $8.60
- AVG Volume (30 Days)
- SFBC 6.1K
- ZNTL 772.3K
- Earning Date
- SFBC 07-29-2025
- ZNTL 08-08-2025
- Dividend Yield
- SFBC 1.65%
- ZNTL N/A
- EPS Growth
- SFBC 59.67
- ZNTL N/A
- EPS
- SFBC 2.44
- ZNTL N/A
- Revenue
- SFBC $38,045,000.00
- ZNTL $26,865,000.00
- Revenue This Year
- SFBC N/A
- ZNTL N/A
- Revenue Next Year
- SFBC N/A
- ZNTL N/A
- P/E Ratio
- SFBC $18.90
- ZNTL N/A
- Revenue Growth
- SFBC 8.26
- ZNTL N/A
- 52 Week Low
- SFBC $43.00
- ZNTL $1.01
- 52 Week High
- SFBC $55.99
- ZNTL $5.44
- Technical
- Relative Strength Index (RSI)
- SFBC 44.59
- ZNTL 46.92
- Support Level
- SFBC $44.00
- ZNTL $1.34
- Resistance Level
- SFBC $48.50
- ZNTL $1.48
- Average True Range (ATR)
- SFBC 1.28
- ZNTL 0.08
- MACD
- SFBC 0.14
- ZNTL -0.01
- Stochastic Oscillator
- SFBC 38.89
- ZNTL 21.74
About SFBC Sound Financial Bancorp Inc.
Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.